MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer
Junpeng Sun, Ziyong Wang, Maofa Yang, Zijian Tan, Hong Sun, Xusong Pang, Longguo Dai, Siting Wang, Kun Zhang, Tenglu Ma, Zhao Cao, Hong Yang · 2026
Read MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer by Junpeng Sun, Ziyong Wang, Maofa Yang, Zijian Tan, Hong Sun, Xusong Pang, Longguo Dai, Siting Wang, Kun Zhang, Tenglu Ma, Zhao Cao, Hong Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13581660.txt.
Description
Junpeng Sun leads a team studying recurrence risk in bladder cancer in a 2026 paper. They focus on patients whose MRI score placed them in the VI-RADS 2 group with non-muscle-invasive disease. Risk in this group varied more than the single label suggests.
The study used records from 342 patients, split into training and validation groups. Six factors were kept, most of them MRI measures of tumor size, contact, and diffusion, plus tumor number. A random survival forest model sorted patients into risk groups far better than standard clinical tools. The authors say MRI measures may add to routine checks, but outside testing is still needed.
Catalog record
| CREATOR | Junpeng Sun, Ziyong Wang, Maofa Yang, Zijian Tan, Hong Sun, Xusong Pang, Longguo Dai, Siting Wang, Kun Zhang, Tenglu Ma, Zhao Cao, Hong Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |